Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study

被引:15
|
作者
Liao, Li-zhen [1 ,2 ]
Li, Wei-dong [1 ,2 ]
Liu, Ying [1 ,2 ]
Li, Jia-ping [3 ]
Zhuang, Xiao-dong [3 ]
Liao, Xin-xue [3 ]
机构
[1] Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Engn Res Ctr Light & Hlth, Guangzhou Higher Educ Mega Ctr, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China
关键词
Mendelian randomization; Omega-6; Coronary heart disease; Genome wide association study; Total cholesterol; Low-density lipoprotein cholesterol; DIETARY FATTY-ACIDS; SERUM-LIPIDS; METAANALYSIS; ASSOCIATION; RISK; CHOLESTEROL; RATIO; N-6;
D O I
10.1016/j.numecd.2019.09.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Evidence on the effect of omega-6 fats on coronary heart disease (CHD) risk remains inconclusive. We applied a network MR framework to determine the causal effects between omega-6 levels and CHD and the potential cholesterol metabolic risk factors (Total cholesterol, TC; Low-density lipoprotein cholesterol, LDL-C; High-density lipoprotein cholesterol, HDL-C; Triglycerides, TG) which might act as mediators in the link between omega-6 levels and CHD by integrating summary-level genome wide association study (GWAS) data. Methods and results: Network MR analysis-an approach using genetic variants as the instrumental variables for both the exposure and mediator to infer causality was performed to examine the causal effects between omega-6 levels and CHD and cholesterol metabolic risk factors. Summary statistics from the Kettunen et al. 's consortium were used (n = 13506) for omega-6, CARDIoGRAMplusC4D consortium data were used (n = 184305) for CHD, and GLGC consortia data were used (n = 108363) for TC, LDL-C, HDL-C, and TG. The IVW method estimate indicated that the odds ratio (OR) (95% confidence interval [CI]) for CHD was 1.210 (1.118-1.310) per standard deviation increase in omega-6. Results were consistent in MR Egger method (OR, 1.418; 95% CI, 1.087-1.851; P = 0.050) and weighted median methods (OR, 1.239; 95% CI, 1.125-1.364; P = 0.000). Omega-6 was positively causal associated with TC, LDL-C, and TG but was not associated with HDL-C. Moreover, TC, LDL-C, and TG were positively associated with CHD. Conclusions: Using a network MR framework, we provided evidence supporting a positive causal relationship between omega-6 and CHD, which might be partially mediated by TC, LDL-C, and TG. (C) 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 50 条
  • [41] Bidirectional causal relationship between hypercholesterolemia and ischemic heart disease: a Mendelian randomization study
    Jiang, Ying
    Yu, Wenpeng
    Zhou, Jianliang
    Dong, Xiao
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [42] Omega-6 fatty acids and risk of cardiovascular disease: insight from systematic review and meta-analysis of randomized controlled trials and a mendelian randomization study
    Mazidi, M.
    Shekoohi, N.
    Katsiki, N.
    Banach, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2836 - 2836
  • [43] Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future
    Burgess, Stephen
    Harshfield, Eric
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2016, 23 (02) : 124 - 130
  • [44] Waist circumference increases risk of coronary heart disease: Evidence from a Mendelian randomization study
    Chen, Qinchang
    Li, Lingling
    Yi, Junzhe
    Huang, Kai
    Shen, Runnan
    Wu, Ridong
    Yao, Chen
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (04):
  • [45] Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study
    Mazidi, Mohsen
    Shekoohi, Niloofar
    Katsiki, Niki
    Banach, Maciej
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (02) : 466 - 479
  • [46] Birth Weight, Cardiometabolic Factors, and Coronary Heart Disease: A Mendelian Randomization Study
    Su, Shuyao
    Fan, Jingwen
    Yang, Yongli
    Yang, Chaojun
    Jia, Xiaocan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11): : E1245 - E1252
  • [47] Network Mendelian Randomization Study Design to Assess Factors Mediating the Causal Link Between Telomere Length and Heart Disease
    Morgan, R. Garrett
    CIRCULATION RESEARCH, 2017, 121 (03) : 200 - 202
  • [48] Hypertriglyceridemia and coronary heart disease in type 1 diabetes: a Mendelian randomization study
    Stechemesser, Lars
    Forsblom, Carol
    Panduru, Nicolae
    Toppila, Iiro
    Taskinen, Marja-Riitta
    Paulweber, Bernhard
    Weitgasser, Raimund
    Groop, Per-Henrik
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 171 - 172
  • [49] Osteoporosis and coronary heart disease: a bi-directional Mendelian randomization study
    Zhang, Junsheng
    Xu, Pai
    Liu, Rongcan
    Gyu, Jin Min
    Cao, Peng
    Kang, Chan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [50] Inflammatory bowel disease and risk of coronary heart diseaseA Mendelian randomization study
    Xue Qiu
    Chenyang Hou
    Zihong Yang
    Qiang Wang
    Lang Li
    Wiener klinische Wochenschrift, 2022, 134 : 779 - 787